Clinical Trial Update: High Dose Steroid Therapy (Prednisone or Methylprednisolone) for the Improvement of Symptoms of Late Radiation-Associated Lower Cranial Neuropathy in Oropharyngeal Cancer Survivors [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 1/2 study evaluating high-dose prednisone or methylprednisolone to improve symptoms of radiation-associated lower c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cranial Nerve Disorder
• Head and Neck Cancer
• Oropharyngeal Cancer

Drugs mentioned

• METHYLPREDNISOLONE (methylprednisolone)
• PREDNISONE (Prednisone)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Cranial Nerve Disorder, Head and Neck Carcinoma | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING